A Multicenter, Double-blind, Parallel Phase III Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Choi Won Seck, M.D
Korea University Ansan Hospital
Study Director - Jeong Suk In
Chonnam Natinal University Hospital
Study Director - Kim Sin Woo
Kyungpook National University Hospital
Study Director - Kim Tae Hyung
Soon Chun Hyang Univ. Hospital
Study Director - Lee Ja Cob
Hallym Univ. Medical Center
Study Director - Lee Jin Su, M.D
Inha University Hospital
Study Director - Wi Sung Heon
St Vincent's Hospital
Study Director - Woo Heong Jung
Hallym Univ. Medical Center
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Korea University Guro Hospital
Seoul, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2014
- Primary completion
- 31 Dec 2014
- Completion
- 31 Jul 2015
- Last update posted
- 20 Oct 2015
- Registered enrollment
- 1,299
- Registry id
- NCT02352584
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.